Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

Labour's Future Fund: a shaky policy debut
Opinion

Pattrick Smellie: Labour's Future Fund: a shaky policy debut

Labour's NZ Future Fund is more sizzle than sausage.

Pattrick Smellie 21 Oct 2025
RBNZ and the curious case of prudential stacks
Opinion

Andy Macdonald: RBNZ and the curious case of prudential stacks

The end result of the RBNZ’s capital review will be both revealing and fascinating.

Andy Macdonald 21 Oct 2025
Why govts can’t leave private assets alone
Opinion

David Chaplin: Why govts can’t leave private assets alone

Will politicians eventually ruin the reputation of the KiwiSaver regime?

David Chaplin 21 Oct 2025